Irbesartan combined with low-dose Hydrochlorothiazide for treatment of essential hypertension.
Wenchao Yang
Abstract
Wenchao Yang
Abstract
Objective To investigate the effects of treatment of essential hypertension with irbesartan tablets and low-dose hydrochlorothiazide tablets.Methods 132 outpatients undergoing essential hypertension were randomly divided into treatment group(T) with 78 cases and control group(C) with 54 cases.In group C,irbesartan tablets(150mg) once a day during the first 2 weeks.If systolic blood pressure was greater than 140mmHg and diastolic blood pressure was greater than 90mmHg at the end of the second weeks,irbesartan(300mg) once a day were added respectively to 8 weeks(8 weeks for one course).In group T,irbesartan tables(150mg) combined coith hydrochlorothiazide tablets(12.5mg) once a day during the first 2 weeks.If systolic blood pressure was greater than 140mmHg and diastolic blood pressure was greater than 90mmHg at the end of the second weeks,irbesartan(300mg) once a day were added respectively to 8 weeks(8 weeks for one course).Blood pressure,Glucose and ECG were measured.Results The blood pressure of the two groups were remarkably down,but group T is satisfactory than groups C(88.46%/75.93%),there were significant difference(P0.05).Conclusion Irbesartan combined with low-dose hydrochlorothiazide is better than singly using irbesartan in treatment of essential hypertension.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effects of treatment of essential hypertension with irbesartan tablets and low-dose hydrochlorothiazide tablets.Methods 132 outpatients undergoing essential hypertension were randomly divided into treatment group(T) with 78 cases and control group(C) with 54 cases.In group C,irbesartan tablets(150mg) once a day during the first 2 weeks.If systolic blood pressure was greater than 140mmHg and diastolic blood pressure was greater than 90mmHg at the end of the second weeks,irbesartan(300mg) once a day were added respectively to 8 weeks(8 weeks for one course).In group T,irbesartan tables(150mg) combined coith hydrochlorothiazide tablets(12.5mg) once a day during the first 2 weeks.If systolic blood pressure was greater than 140mmHg and diastolic blood pressure was greater than 90mmHg at the end of the second weeks,irbesartan(300mg) once a day were added respectively to 8 weeks(8 weeks for one course).Blood pressure,Glucose and ECG were measured.Results The blood pressure of the two groups were remarkably down,but group T is satisfactory than groups C(88.46%/75.93%),there were significant difference(P0.05).Conclusion Irbesartan combined with low-dose hydrochlorothiazide is better than singly using irbesartan in treatment of essential hypertension.
Key concepts: Irbesartan, Hydrochlorothiazide, Medicine, Blood pressure, Essential hypertension, Pharmacology, Urology, Internal medicine